Cargando…

(651) Long-Term Safety and Efficacy of Mrna Sars-Cov2 Vaccination in Heart Transplant Recipients

PURPOSE: Data on long-term clinical effects of mRNA SARS-CoV2 vaccination in heart transplant recipients are scarce and conflicting. We investigated the long-term safety and efficacy of mRNA SARS-CoV2 vaccination in this patient population. METHODS: In a prospective single-center cohort study we inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poglajen, G., Žorž, N., Ihan, A., Frljak, S., Cerar, A., Zemljic, G., Okrajsek, R., Sebestjen, M., Vrtovec, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068052/ http://dx.doi.org/10.1016/j.healun.2023.02.665

Ejemplares similares

Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Outcomes of COVID-19 in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
por: Poglajen, Gregor, et al.
Publicado: (2020)

CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy
por: Frljak, Sabina, et al.
Publicado: (2018)

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Stratification of Arrhythmic Risk Using Remote Patient Monitoring in a Heart Transplant Recipient with Coronary Allograft Vasculopathy
por: Žorž, N., et al.
Publicado: (2021)

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Transendocardial CD34(+) Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study
por: Cerar, Andraz, et al.
Publicado: (2018)

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
por: Vrtovec, Bojan, et al.
Publicado: (2022)

Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)

TNF-α Predicts Endothelial Function and Number of CD34(+) Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure
por: Ugovšek, Sabina, et al.
Publicado: (2022)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
por: Frljak, Sabina, et al.
Publicado: (2022)

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2018)

Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)

Prevalence of sustained atrial arrythmias and treatment with zero fluoroscopy or near zero fluoroscopy catheter ablation in Slovenian orthotopic heart transplant recipients
por: Rauber, M, et al.
Publicado: (2023)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
por: Cerar, Andraz, et al.
Publicado: (2020)

Response to the letter to the editor: unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion
por: Cerar, Andraz, et al.
Publicado: (2020)

Endocrine disorders after heart transplantation: national cohort study
por: Rakusa, Matej, et al.
Publicado: (2020)

Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
por: Banovic, Marko, et al.
Publicado: (2022)

Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients
por: Hirama, Takashi, et al.
Publicado: (2022)

Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients
por: Cehic, Matthew G., et al.
Publicado: (2019)

Runs 639, 651 and 656, Tests of the Poleface Windings power supplies
por: Fischer, E, et al.
Publicado: (1976)

NMR assignment of the domain 513–651 from the SARS-CoV nonstructural protein nsp3
por: Chatterjee, Amarnath, et al.
Publicado: (2007)

Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Ślizień, Zuzanna, et al.
Publicado: (2022)

SARS-CoV-2 Infection in the Heart Transplant Recipient
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection
por: Goda, Yasufumi, et al.
Publicado: (2022)

Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients
por: Herrera, Sabina, et al.
Publicado: (2021)

Safety evaluation of the food enzyme α‐amylase from the genetically modified Bacillus subtilis strain AR‐651
por: Lambré, Claude, et al.
Publicado: (2023)

Cryptococcal cellulitis in a heart transplant recipient
por: Ashchyan, Hovik J., et al.
Publicado: (2016)

Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients
por: Zwetsloot, Peter-Paul, et al.
Publicado: (2023)

Run 651, 75-11-3, Vacuum Limit Ring 2
por: Calder, R, et al.
Publicado: (1975)

651. Comparative Analysis Between Bacterial And Fungal Malignant Otitis Externa
por: Hammami, Fatma, et al.
Publicado: (2020)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
por: Hoeeg, Cecilie, et al.
Publicado: (2020)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Vacuum Limit Sector 70 R2 (Run 651, 75-11-3)
por: Mathewson, A
Publicado: (1975)

Immunogenicity of SARS‐CoV‐2 mRNA vaccine in solid organ transplant recipients
por: Holden, Inge K., et al.
Publicado: (2021)

Diabetes control in a primary care setting: a retrospective study of 651 patients
por: Al-Hussein, Fahad A.
Publicado: (2008)

Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
por: Hoffman, T.W., et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination-Induced Immunogenicity in Heart Transplant Recipients
por: Memenga, Felix, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2t080av9rcbn0vpupet7phbkt3